Markets:

Overview

News

Currencies

International

Treasuries

Caribou Biosciences, Inc. - Common Stock (NQ:CRBU)

1.600 -0.010 (-0.62%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Caribou Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU

January 12, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

January 08, 2025

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From Caribou Biosciences, Inc.

Via GlobeNewswire

Expert Ratings For Caribou Biosciences ↗

September 03, 2024

Via Benzinga

Caribou Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

August 14, 2024

Via Benzinga

Evaluating Caribou Biosciences: Insights From 4 Financial Analysts ↗

July 17, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences ↗

June 04, 2024

Via Benzinga

CARIBOU ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Caribou Biosciences, Inc. and Encourages Investors to Contact the Firm

January 06, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit

January 02, 2025

From Robbins LLP

Via GlobeNewswire

Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer

January 02, 2025

From Caribou Biosciences, Inc.

Via GlobeNewswire

Expert Ratings For Caribou Biosciences ↗

May 16, 2024

Via Benzinga

CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

December 31, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

December 26, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Caribou Biosciences to Participate in Upcoming Investor Conferences

November 20, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

November 06, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024

September 25, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML

September 03, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences to Participate in Upcoming Investor Conferences

August 26, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer

August 12, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

August 06, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board

July 09, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 03, 2024

Via Benzinga

Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

June 02, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences

May 30, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Attention Biotech Investors - Stocks To Watch ↗

May 16, 2024

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences,...

Via Benzinga

3 Underappreciated Stocks That Could 10x in 10 Years ↗

May 12, 2024

10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.

Via InvestorPlace

CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024 ↗

May 07, 2024

CRBU stock results show that Caribou Biosciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update

May 07, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

Caribou Biosciences to Participate in Upcoming Investor Conferences

May 01, 2024

From Caribou Biosciences, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.